Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||SPRAY COMPOSITIONS FOR TREATMENT OF OBSTRUCTIVE DISORDERS OF THE RESPIRATORY TRACT AND METHODS THEREFOR|
|Abstract:||Inhalation spray compositions for the treatment of obstructive disorders of the respiratory tract, comprising as an active ingredient a physiologically compatible quaternary salt of N-isopropyl-N-methyl-nortropine tropic acid ester, optionally in combination with a mucolytic and/or a bronchospasmolytic.|
|Inventor(s):||Zeile; Karl (Ingelheim am Rhein, DT), Schulz; Werner (Ingelheim am Rhein, DT), Banholzer; Rolf (Ingelheim am Rhein, DT), Wick; Helmut (Ingelheim am Rhein, DT)|
|Assignee:||Boehringer Ingelheim GmbH (Ingelheim am Rhine, DT)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Compound; Formulation;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|P 19 62 496.5||Dec 12, 1969|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.